
What’s Your Synthetic Biology Strategy?
By analyzing the syn-bio industry stack and understanding its dynamics, incumbents can develop strategies that will gain them competitive advantage.
Almost anything can be created through synthetic biology, and BCG helps clients harness syn-bio capabilities to drive winning strategies in a range of verticals, from food and pharma to clothing and construction.
To many industries, synthetic biology means disruption—but also opportunity. Our synthetic biology consultants help companies understand both how syn-bio can transform their sector and where they can deploy syn-bio technologies in order to achieve lower production costs and greater profits.
合成生物学は、革新的かつ持続可能で、レジリエンスが高く、低コストでの製造や製品開発が可能なマテリアルを創り出す、科学とエンジニアリングを中心としたエマージングテクノロジーです。合成生物学は、自然を利用して、人工タンパク質、プログラム化された細胞、遺伝子組み換えなど、新しい生物学的構成要素・システムを創出したり、既存のものを改良したりします。
BCGは広範なアプローチを通じて、クライアントの合成生物学戦略の策定を支援します。
By analyzing the syn-bio industry stack and understanding its dynamics, incumbents can develop strategies that will gain them competitive advantage.
Synthetic biology is a difficult technology to master and especially tough to scale. Chemical and materials startups and their backers need to find the meeting place of technology capability, market need, and cost.
Synthetic biology technologies are finally maturing, becoming the way almost anything can be manufactured competitively and sustainably. Businesses must learn to use syn-bio to develop new products and processes, improve existing ones, and reduce costs to remain competitive in the future.
A new wave of innovation is coming. Pharma companies need to determine the role they will play in shaping it.
BCGの合成生物学領域のコンサルタントは複雑なディープテックのエキスパートで、大きな課題を解決するためにエマージングテクノロジーを活用します。これらのコンサルタントは、クライアントが有望な事業機会として合成生物学に取り組んだり、合成生物学をワークフローや戦略に取り入れたりするサポートをする態勢を整えています。この領域のエキスパートの一部をご紹介します。